GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (CHIX:IMMUs) » Definitions » Construction In Progress

Mendus AB (CHIX:IMMUS) Construction In Progress : kr0.00 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Mendus AB Construction In Progress?


Mendus AB Construction In Progress Historical Data

The historical data trend for Mendus AB's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB Construction In Progress Chart

Mendus AB Annual Data
Trend Jun14 Jun15 Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mendus AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mendus AB Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Mendus AB (CHIX:IMMUS) Business Description

Traded in Other Exchanges
Address
Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company that focuses on the development of immunotherapies that address tumor recurrence and difficult-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.

Mendus AB (CHIX:IMMUS) Headlines

No Headlines